Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Paradigm Biopharmaceuticals Ltd. announced that Dr. Donna Skerrett has stepped down from her role as Executive Director but will continue as Chief Medical Officer, focusing on the company’s phase 3 clinical program and upcoming New Drug Application. Dr. Skerrett’s leadership has been pivotal in advancing Paradigm’s strategic initiatives, and her continued involvement is expected to bolster the company’s efforts in bringing innovative therapies to market. This development underscores Paradigm’s commitment to achieving its strategic goals in drug development.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
